n this issue, Dr. Judith Balk and colleagues report on the basis, compared with estradiol-173.2' Relative to estradioleffects of phytoestrogen supplementation on postmeno-17P, soy isoflavones have a greater (seven times) affinity for pausal endometrium. This study is distinguished by its ER3 than ERot.22 Thus the tissue-specific responses to isoflalength (6 months), and it confirms data in shorter studies that vones can be explained partly by the relative ER (cx or ) show no effect on endometrial proliferation." 2 Much of the concentration in the tissue under study. There have also been data on phytoestrogens and soy in particular suggest that these suggestions that the estrogen level in the tissue might modulate compounds behave like weak selective estrogen receptor modthe cellular response. In premenopausal women with high ulators. Their tissue-selective estrogenicity is a subject of deestrogen levels, isoflavones might act as an estrogen antagonist; bate,2 as some studies have found positive effects on hot whereas in women with lower levels after menopause, they flashes,37 whereas others have not,8'9 as well as variable effects might act as an estrogen agonist.20 23 Other actions could on vaginal cornification and gonadotropin suppression. 60,11l involve antioxidation or enzyme inhibition,24'25 or stimulation Most of these studies, however, did not follow strict guidelines of sex hormone binding globulin, which decreases the biofor scientific validity. Some studies have also suggested estro-availability of sex steroids.12"13 Recent data from monkey genicity by virtue of increased sex hormone binding globustudies also suggest that a synergism may occur between soy lin.I>14 To date, however, there have been no reports of and estradiol in certain tissues, such as the coronary endotheendometrial stimulation, although studies have found increased lium. In a recent study, augmented coronary vasodilation was uterine weight in rats.15 found with soy in the presence of estrogen, whereas no effect More women are using soy or other natural substitutes for was found for soy alone.26 estrogen to treat menopausal symptoms in an attempt to find Overall, the news regarding soy and the endometrium is natural alternatives, with 71% ofwomen believing there are no positive, as proliferation does not appear to occur. What rerisks and 61.8% believing they are equally or more effective for mains uncertain, and more difficult to test, is the role of treating menopausal symptoms.'6 The lack of evidence-based isoflavones on breast tissue. Japanese women, with a diet rich studies is problematic for physicians, and the published studies in soy protein, have one of the lowest breast cancer rates in the are further not comparable because of use of different proto-world. However, adoption of a westem diet apparently elimcols, different doses, and different forms of the active ingrediinates that protection. Some data suggest that isoflavones have ents of soy, either the isoflavone extract or the whole soy a protective effect on the breast, including antiproliferative and protein. As an example, in her study, Dr. Balk reports on antiangiogentic effects of genistein2728; and lower levels of subjects with only one to two hot flashes per week, and with isoflavonoids have been found in the urine of women with this small number of hot flashes a significant decrease was breast cancer compared with controls.29 However, low conreported. Other studies reporting more hot flashes (20-50 per centrations of isoflavones may cause growth stimulation of week) have shown no effects. Also, the dose used in this study breast cancer cells, suggesting a weak estrogenic effect.3" 3' was 100 mg of isoflavones via soy flour and corn cereal, a dose In summary, soy appears to have complicated but weak generally larger than that in the average Japanese diet, which is selective ER modulator-like effects on different tissues. Its role approximately 55 mg per day.'7 Nevertheless, it is reassuring in treating symptoms of menopause and long-term illnesses, that at this dose no effect was noted on the endometrium after such as cardiovascular disease, osteoporosis, and Alzheimer's 6 months. disease, remains controversial.'4'20 Because the carcinogenic The effectiveness of isoflavones on estrogen-related sympeffects of estrogen on the endometrium are known to be toms and tissue is further complicated by the complexity of the directly related to proliferative effects, Dr. Balk's article is action of estrogen-like compounds. Tissues that respond to reassuring that soy in these doses for 6 months does not appear estrogen differ in their sensitivities because of the differing to increase endometrial cancer risk. populations of estrogen receptor (ER) subtypes, the differing action of proteins involved in gene expression, and probably REFERENCES other factors as well.'8-211 The ability of isoflavones to bind to 1. Han KK, Soares JM Jr, Haidar MA, de Lima GR, Bacarat EC. ERs and produce estrogenic responses has been shown in a --r _L 1I
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